ProfileGDS4095 / 214901_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 71% 70% 70% 69% 70% 71% 69% 70% 71% 70% 70% 68% 70% 69% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep16.910471
GSM709769LY2 SRC1-siRNA tamoxifen treated rep36.8239470
GSM709765LY2 SRC1-siRNA untreated rep36.6909170
GSM709771LY2 SRC1-siRNA untreated rep16.6559269
GSM709772LY2 SRC1-siRNA untreated rep26.8527870
GSM709775LY2 SRC1-siRNA untreated rep46.9140871
GSM709764LY2 control-siRNA tamoxifen treated rep26.5596869
GSM709766LY2 control-siRNA tamoxifen treated rep36.6819870
GSM709768LY2 control-siRNA tamoxifen treated rep16.9420671
GSM709777LY2 control-siRNA tamoxifen treated rep46.701370
GSM709770LY2 control-siRNA untreated rep36.9106370
GSM709773LY2 control-siRNA untreated rep16.4267168
GSM709774LY2 control-siRNA untreated rep26.8596170
GSM709776LY2 control-siRNA untreated rep46.5017269